Free Trial

Alto Neuroscience (ANRO) SEC Filings & 10K Form

Alto Neuroscience logo
$2.45 -0.05 (-2.00%)
As of 03:57 PM Eastern

Recent Alto Neuroscience SEC Filings

DateFilerForm TypeView
06/03/2025
5:34 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:19 PM
Alto Neuroscience (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
Form SCHEDULE 13G
05/15/2025
2:05 PM
Alto Neuroscience (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
04/01/2025
3:25 PM
Alto Neuroscience (Filer)
Form ARS
03/20/2025
4:15 PM
Alto Neuroscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:32 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
3:36 PM
Alto Neuroscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:26 PM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
7:16 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
11:15 PM
Alto Neuroscience (Filer)
Form EFFECT
02/03/2025
3:39 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
3:07 PM
Alto Neuroscience (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/16/2025
6:00 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
6:00 AM
Alto Neuroscience (Subject)
Etkin Amit (Filed by)
Form SC 13G
10/22/2024
3:35 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
Alto Neuroscience (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/13/2024
3:33 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:36 PM
Alto Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
3:19 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ANRO) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners